GleamWall
中文EN

CMPS COMPASS Pathways plc

Pharmaceutical Preparations · Nasdaq · SEC CIK 1816590 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-12.2%
TTM EPS YoY14.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-296.5%
ROA-68.7%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets72.6%
Debt / equity0.36x
Current ratio1.50x
Interest coverage-35.36x

Cash quality & payout

Operating cash flow / net income0.66x
Accruals ratio-23.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$118.44M$119.04M
SG&A expense$60.60M$59.17M
Operating income-$179.04M-$178.21M
Interest expense$4.52M$4.48M
Pretax income-$290.33M-$153.53M
Income tax-$2.47M$1.59M
Net income-$287.86M-$155.12M
EBITDA-$178.82M-$177.97M
EPS (basic)-3.08-2.30
EPS (diluted)-3.08-2.30
Weighted avg. shares (diluted)93.50M67.48M
Balance sheet
Cash & equivalents$149.61M$165.47M
Current assets$191.49M$201.29M
PP&E, net—$189,000
Total assets$210.35M$213.67M
Current liabilities$247.79M$34.02M
Short-term debt$17.52M$5.51M
Long-term debt$14.11M$24.65M
Total debt$31.63M$30.16M
Total liabilities$263.20M$58.97M
Shareholders' equity-$52.85M$154.69M
Net debt-$117.97M-$135.31M
Shares outstanding96.09M68.55M
Cash flow statement
Operating cash flow-$157.24M-$119.19M
Capital expenditure—$0
Free cash flow—-$119.19M
Investing cash flow—$0
Financing cash flow$140.71M$63.82M
Depreciation & amortization$216,000$233,000
Stock-based compensation$13.59M$19.52M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.